This module will provide an in-depth understanding of cutting-edge technologies currently used in both basic science laboratories and clinical diagnostic laboratories for translational genetic, epigenetic and transcriptomic research. The module will cover both classical techniques such as Sanger sequencing and new technologies including semi-conductor-based sequencing (as observed in the Ion Torrent). It will illustrate how the understanding of genomics provides insights into cancer diagnosis, stratification and treatment. It will evaluate the latest information on current drug developments and stratified medicine initiatives, and how these research themes are being translated in the clinic.
20 Masters level credits
Module attendance required
Module taken over 2 weeks.
21 October – 1 November 2019
Summatively assessed with a 10 short answer question (SAQ) exam (2h) (60%) and with a 3000 word essay (40%).
Academics involved in the delivery of this module
Professor Jo Morris and Dr Clare Davies, with lecturers drawn from both the University of Birmingham and the National Health Service in order to deliver a module that teaches
both the basics of the technologies and their clinical relevance. Lectures will also be provided by bioinformaticians within the University, who will illustrate how dataset analyses can unpick the relevant biology of a disease.
Please rest assured that we will make all reasonable efforts to provide you with the courses, services and facilities described. However, it may be necessary to make changes due to significant disruption, for example in response to COVID-19.
Information for future students and applicants
Coronavirus (COVID-19) latest updates and FAQs for future students and offer-holdersVisit our FAQs